Crescent Capital BDC (NASDAQ:CCAP) Announces Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.46 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.01), Zacks reports. Crescent Capital BDC had a return on equity of 9.71% and a net margin of 20.84%.The business had revenue of $41.35 million for the quarter, compared to analyst estimates of $42.35 million.

Crescent Capital BDC Price Performance

CCAP stock remained flat at $13.59 during mid-day trading on Friday. 50,209 shares of the company’s stock were exchanged, compared to its average volume of 193,321. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 1.22. The company’s fifty day moving average price is $14.55 and its 200 day moving average price is $14.86. Crescent Capital BDC has a 12 month low of $13.30 and a 12 month high of $20.19.

Crescent Capital BDC Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st will be given a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a dividend yield of 12.4%. The ex-dividend date is Wednesday, December 31st. Crescent Capital BDC’s dividend payout ratio is 140.00%.

Insider Activity

In other news, Director Raymond Barrios purchased 3,245 shares of the business’s stock in a transaction dated Monday, August 25th. The stock was acquired at an average price of $15.63 per share, for a total transaction of $50,719.35. Following the acquisition, the director directly owned 19,177 shares of the company’s stock, valued at approximately $299,736.51. This represents a 20.37% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Institutional Investors Weigh In On Crescent Capital BDC

A number of institutional investors have recently modified their holdings of the company. XTX Topco Ltd purchased a new stake in shares of Crescent Capital BDC during the second quarter worth $165,000. Seven Mile Advisory acquired a new position in shares of Crescent Capital BDC in the 3rd quarter valued at $189,000. Quantbot Technologies LP purchased a new stake in shares of Crescent Capital BDC in the 2nd quarter valued at about $219,000. Jump Financial LLC acquired a new stake in Crescent Capital BDC during the 2nd quarter worth approximately $286,000. Finally, Invesco Ltd. grew its stake in shares of Crescent Capital BDC by 31.4% in the 2nd quarter. Invesco Ltd. now owns 38,377 shares of the company’s stock valued at $541,000 after purchasing an additional 9,180 shares during the last quarter. 49.46% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CCAP has been the subject of a number of research analyst reports. Zacks Research lowered shares of Crescent Capital BDC from a “hold” rating to a “strong sell” rating in a research report on Wednesday, October 15th. Wells Fargo & Company dropped their price target on shares of Crescent Capital BDC from $15.00 to $14.00 and set an “equal weight” rating on the stock in a research note on Friday. Keefe, Bruyette & Woods reduced their price objective on Crescent Capital BDC from $17.00 to $15.50 and set an “outperform” rating for the company in a research report on Friday. Finally, LADENBURG THALM/SH SH upgraded Crescent Capital BDC to a “strong-buy” rating in a report on Friday, August 15th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Crescent Capital BDC currently has a consensus rating of “Moderate Buy” and a consensus target price of $15.50.

Read Our Latest Analysis on CCAP

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Read More

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.